Recent Quotes (30 days)

You have no recent quotes
chg | %

MedTech Global Ltd.  

(Public, ASX:MDG)   Watch this stock  
Find more results for ASX: MDG
- Close
ASX data delayed by 20 mins - Disclaimer
Currency in
Range     -
52 week 0.05 - 0.14
Open     -
Vol / Avg. 0.00/8,964.00
Mkt cap     -
P/E     -
Div/yield     -
EPS -0.02
Shares 100.25M
Beta     -
Inst. own     -

Key stats and ratios

Q3 (Sep '16) 2016
Net profit margin -10.84% -11.29%
Operating margin -12.80% -10.36%
EBITD margin - 6.39%
Return on average assets -26.63% -22.81%
Return on average equity -160.31% -55.26%
Employees 9 -
CDP Score - -


L 2 99 Coventry St
+61-3-96908666 (Phone)
+61-3-96908010 (Fax)

Website links


Medtech Global Limited is a health information technology company. The principal activities are business and sale by the way of sub-license of healthcare technologies across the world. Its segments include Australia, New Zealand & India (NZ & INDIA), and the United States of America (USA). The Australia, and New Zealand & India segments operate primarily in software development and licensing of healthcare and e-business solutions. The USA segment operates in healthcare containment services. Its products include primary health, which includes Medtech Evolution General Practice, Medtech Evolution Specialist and Medtech32; secondary health, which includes Evolution Hospital Information System (HIS), MD Analyze and Shared EHR; personal and telehealth, which includes ManageMyHealth, ManageMyHealth Mobile and VitelMed; data intelligence, which includes Clinical Business Intelligence Tool (CBIT) and MD Analyze, and data mobility, which includes ConnectedCare and Medtech Cloud solutions.